SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo
📖

MDS 2026

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-events-mds-2026
Related Entities
events-mds-2026
Metadata
slugevents-mds-2026
entity_typeevent
kg_node_idNone
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (105)
mentions🧫4R-Tau Targeting Therapies for PSP and CBS70%
mentions🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back70%
mentions🧫Computational Modeling of Alpha-Synuclein Propagation in PD70%
mentions🧫Alpha-Synuclein Seed Amplification Assay Validation70%
mentions🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri70%
mentions🧫Antiviral Therapy Trial for Parkinson's Disease70%
mentions🧫Brainstem Circuit Modulation for PSP70%
mentions🧫cGAS-STING Pathway Validation Study in Parkinson's Dise70%
mentions🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#70%
mentions🧫Endocannabinoid System Dysfunction Validation in Parkinson&#70%
mentions🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
mentions🧫GLP-1 Agonist Neuroprotection Mechanism in PD70%
mentions🧫GLP-1 Agonist Responder Prediction Study — Precision Medicin70%
mentions🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&70%
mentions🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me70%
mentions🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre70%
mentions🧫Cytochrome Therapeutics70%
mentions🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne70%
mentions🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr70%
mentions🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%
mentions🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper70%
mentions🧫Non-Motor Symptom Progression in Parkinson's Disease — 70%
mentions🧫Parkinson's Disease Subtype Classification — Precision 70%
mentions🧫Peroxisome Dysfunction Validation in Parkinson's Diseas70%
mentions🧫Prodromal Parkinson's Disease Biomarker Development — E70%
mentions🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%
mentions🧫PSP and CBS Biomarker Validation Study70%
mentions🧫Purinergic Signaling Dysfunction Validation in Parkinson70%
mentions🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D70%
mentions🧫Tau Pathology Initiation Zone Identification70%
related🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera70%
related🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera70%
related🧫4R-Tau Targeting Therapies for PSP and CBS63%
related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back63%
related🧫Computational Modeling of Alpha-Synuclein Propagation in PD63%
related🧫Alpha-Synuclein Seed Amplification Assay Validation63%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri63%
related🧫Antiviral Therapy Trial for Parkinson's Disease63%
related🧫Brainstem Circuit Modulation for PSP63%
related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise63%
related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#63%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#63%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De63%
related🧫GLP-1 Agonist Neuroprotection Mechanism in PD63%
related🧫GLP-1 Agonist Responder Prediction Study — Precision Medicin63%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&63%
related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me63%
related🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre63%
related🧫Cytochrome Therapeutics63%
related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne63%
related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr63%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag63%
related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper63%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 63%
related🧫Parkinson's Disease Subtype Classification — Precision 63%
related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas63%
related🧫Prodromal Parkinson's Disease Biomarker Development — E63%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin63%
related🧫PSP and CBS Biomarker Validation Study63%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson63%
related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D63%
related🧫Tau Pathology Initiation Zone Identification63%
related🧪Smartphone-Detected Motor Variability Correction50%
related🧪Enteric Nervous System Prion-Like Propagation Blockade50%
related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying protein aggregation cross50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di50%
related🔬Extracellular vesicle biomarkers for early AD detection50%
related🔬Comprehensive analysis of immune cell subtypes in neurodegen50%
related🔬What cell types are most vulnerable in Alzheimers Disease ba50%
related🔬What cell types are most vulnerable in Alzheimer's Dise50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
related🔬Senescent cell clearance as neurodegeneration therapy50%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
related🔬What are the mechanisms underlying apoe4 structural biology 40%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa40%
related🔬What are the mechanisms underlying digital biomarkers and ai40%
related🔬What are the mechanisms underlying senolytic therapy for age40%
related🔬What are the mechanisms underlying what are the mechanisms b40%
related🔬What are the mechanisms underlying what are the mechanisms b40%
related🔬What are the mechanisms underlying protein aggregation cross40%
related🔬What are the mechanisms underlying rna binding protein dysre40%
related🔬What are the mechanisms underlying synaptic pruning by micro40%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di40%
related🔬Extracellular vesicle biomarkers for early AD detection40%
related🔬Comprehensive analysis of immune cell subtypes in neurodegen40%
related🔬What cell types are most vulnerable in Alzheimers Disease ba40%
related🔬What cell types are most vulnerable in Alzheimer's Dise40%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc40%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc40%
related🔬Senescent cell clearance as neurodegeneration therapy40%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas40%
SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub